GT
AMGN icon

Glenview Trust’s Amgen AMGN Stock Holding History

Glenview Trust’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75M Sell
7,821
-36
-0.5% -$12.8K 0.04% 202
2025
Q4 		$2.57M Sell
7,857
-554
-7% -$176K 0.04% 208
2025
Q3 		$2.37M Sell
8,411
-61
-0.7% -$17.7K 0.04% 213
2025
Q2 		$2.37M Sell
8,472
-56
-0.7% -$15.9K 0.04% 207
2025
Q1 		$2.66M Sell
8,528
-135
-2% -$39.9K 0.05% 193
2024
Q4 		$2.26M Sell
8,663
-717
-8% -$213K 0.04% 195
2024
Q3 		$3.02M Sell
9,380
-49
-0.5% -$16K 0.06% 177
2024
Q2 		$2.95M Sell
9,429
-168
-2% -$49.4K 0.06% 170
2024
Q1 		$2.73M Buy
9,597
+105
+1% +$30.7K 0.06% 177
2023
Q4 		$2.73M Buy
9,492
+323
+4% +$88K 0.07% 170
2023
Q3 		$2.46M Sell
9,169
-78
-0.8% -$19.5K 0.07% 158
2023
Q2 		$2.05M Buy
9,247
+146
+2% +$33.9K 0.06% 174
2023
Q1 		$2.2M Buy
9,101
+110
+1% +$27K 0.07% 170
2022
Q4 		$2.36M Sell
8,991
-228
-2% -$61.1K 0.08% 154
2022
Q3 		$2.08M Buy
9,219
+58
+0.6% +$14.1K 0.08% 148
2022
Q2 		$2.23M Buy
9,161
+674
+8% +$165K 0.08% 146
2022
Q1 		$2.05M Buy
8,487
+999
+13% +$230K 0.07% 158
2021
Q4 		$1.68M Sell
7,488
-275
-4% -$58K 0.06% 166
2021
Q3 		$1.65M Sell
7,763
-319
-4% -$73.4K 0.06% 159
2021
Q2 		$1.97M Buy
8,082
+60
+0.7% +$14.8K 0.08% 148
2021
Q1 		$2M Buy
8,022
+1,047
+15% +$250K 0.09% 138
2020
Q4 		$1.6M Sell
6,975
-50
-0.7% -$11.5K 0.07% 150
2020
Q3 		$1.78M Sell
7,025
-9
-0.1% -$2.23K 0.09% 133
2020
Q2 		$1.66M Sell
7,034
-180
-2% -$41.1K 0.09% 136
2020
Q1 		$1.46M Buy
7,214
+644
+10% +$141K 0.1% 136
2019
Q4 		$1.58M Buy
6,570
+676
+11% +$149K 0.09% 149
2019
Q3 		$1.14M Buy
5,894
+560
+10% +$107K 0.07% 167
2019
Q2 		$983K Sell
5,334
-1,483
-22% -$266K 0.06% 179
2019
Q1 		$1.29M Buy
6,817
+154
+2% +$29.4K 0.08% 167
2018
Q4 		$1.3M Buy
6,663
+500
+8% +$97.5K 0.1% 161
2018
Q3 		$1.28M Buy
+6,163
New +$1.21M 0.08% 167
2018
Q2 		– Sell
-6,255
Closed -$1.07M – 309
2018
Q1 		$1.07M Sell
6,255
-21
-0.3% -$3.85K 0.07% 173
2017
Q4 		$1.09M Buy
6,276
+71
+1% +$12.6K 0.08% 171
2017
Q3 		$1.16M Buy
6,205
+68
+1% +$12K 0.08% 158
2017
Q2 		$1.06M Buy
6,137
+25
+0.4% +$4.07K 0.08% 160
2017
Q1 		$1M Buy
6,112
+81
+1% +$13.5K 0.08% 161
2016
Q4 		$882K Buy
+6,031
New +$908K 0.07% 168
2015
Q4 		$518K Buy
+3,194
New +$502K 0.05% 175
2014
Q4 		$393K Buy
+2,469
New +$385K 0.04% 178
2013
Q4 		$277K Buy
+2,431
New +$277K 0.03% 194

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Glenview Trust's AMGN Position: Q1 2026 in Review

Glenview Trust reduced its Amgen (AMGN) stake by 0.46% in Q1 2026, selling an estimated $12.8K and leaving 7,821 shares worth $2.75M. The position accounts for 0.04% of the portfolio, ranked #202.

Glenview Trust first reported a position in AMGN in Q4 2013 and has held it in 40 quarters since. The position peaked at $3.02M in Q3 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Glenview Trust held 7,821 shares of Amgen worth $2.75M as of Q1 2026.
  • Glenview Trust sold 36 Amgen shares in Q1 2026, an estimated $12.8K.
  • Amgen made up 0.04% of Glenview Trust's portfolio in Q1 2026, its #202 holding.
  • Glenview Trust first reported a position in Amgen in Q4 2013 and has held it in 40 quarters since.
  • Glenview Trust's Amgen position peaked at $3.02M in Q3 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.